IBDEI0YH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17134,1,1,0)
 ;;=1^282.1
 ;;^UTILITY(U,$J,358.3,17134,1,8,0)
 ;;=8^Hereditary Elliptocytosis
 ;;^UTILITY(U,$J,358.3,17134,2)
 ;;=^39378
 ;;^UTILITY(U,$J,358.3,17135,0)
 ;;=282.2^^111^1075^8
 ;;^UTILITY(U,$J,358.3,17135,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17135,1,1,0)
 ;;=1^282.2
 ;;^UTILITY(U,$J,358.3,17135,1,8,0)
 ;;=8^Anemias d/t Diso of Glutathione
 ;;^UTILITY(U,$J,358.3,17135,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,17136,0)
 ;;=282.3^^111^1075^35
 ;;^UTILITY(U,$J,358.3,17136,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17136,1,1,0)
 ;;=1^282.3
 ;;^UTILITY(U,$J,358.3,17136,1,8,0)
 ;;=8^Oth Hemolytic Anemias d/t Enzyme
 ;;^UTILITY(U,$J,358.3,17136,2)
 ;;=^267980
 ;;^UTILITY(U,$J,358.3,17137,0)
 ;;=282.40^^111^1075^54
 ;;^UTILITY(U,$J,358.3,17137,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17137,1,1,0)
 ;;=1^282.40
 ;;^UTILITY(U,$J,358.3,17137,1,8,0)
 ;;=8^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,17137,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,17138,0)
 ;;=282.42^^111^1075^48
 ;;^UTILITY(U,$J,358.3,17138,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17138,1,1,0)
 ;;=1^282.42
 ;;^UTILITY(U,$J,358.3,17138,1,8,0)
 ;;=8^Sickle-cell Thalassemia w/ Crisis
 ;;^UTILITY(U,$J,358.3,17138,2)
 ;;=^329909
 ;;^UTILITY(U,$J,358.3,17139,0)
 ;;=282.43^^111^1075^4
 ;;^UTILITY(U,$J,358.3,17139,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17139,1,1,0)
 ;;=1^282.43
 ;;^UTILITY(U,$J,358.3,17139,1,8,0)
 ;;=8^Alpha Thalessemia
 ;;^UTILITY(U,$J,358.3,17139,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,17140,0)
 ;;=282.44^^111^1075^12
 ;;^UTILITY(U,$J,358.3,17140,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17140,1,1,0)
 ;;=1^282.44
 ;;^UTILITY(U,$J,358.3,17140,1,8,0)
 ;;=8^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,17140,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,17141,0)
 ;;=282.45^^111^1075^15
 ;;^UTILITY(U,$J,358.3,17141,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17141,1,1,0)
 ;;=1^282.45
 ;;^UTILITY(U,$J,358.3,17141,1,8,0)
 ;;=8^Delta-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,17141,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,17142,0)
 ;;=282.46^^111^1075^53
 ;;^UTILITY(U,$J,358.3,17142,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17142,1,1,0)
 ;;=1^282.46
 ;;^UTILITY(U,$J,358.3,17142,1,8,0)
 ;;=8^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,17142,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,17143,0)
 ;;=282.47^^111^1075^19
 ;;^UTILITY(U,$J,358.3,17143,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17143,1,1,0)
 ;;=1^282.47
 ;;^UTILITY(U,$J,358.3,17143,1,8,0)
 ;;=8^Hemoglobin E-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,17143,2)
 ;;=^340498
 ;;^UTILITY(U,$J,358.3,17144,0)
 ;;=282.49^^111^1075^42
 ;;^UTILITY(U,$J,358.3,17144,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17144,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,17144,1,8,0)
 ;;=8^Oth Thalassemia
 ;;^UTILITY(U,$J,358.3,17144,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,17145,0)
 ;;=282.5^^111^1075^49
 ;;^UTILITY(U,$J,358.3,17145,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17145,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,17145,1,8,0)
 ;;=8^Sickle-cell Trait
 ;;^UTILITY(U,$J,358.3,17145,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,17146,0)
 ;;=282.60^^111^1075^47
 ;;^UTILITY(U,$J,358.3,17146,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17146,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,17146,1,8,0)
 ;;=8^Sickle-cell Disease Unspec
 ;;^UTILITY(U,$J,358.3,17146,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,17147,0)
 ;;=282.62^^111^1075^17
 ;;^UTILITY(U,$J,358.3,17147,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17147,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,17147,1,8,0)
 ;;=8^Hb-SS Disease w/ Crisis
